LVIS Corporation
PrivateLast Round
Series B
Extension
Jan 11, 2022
Est. Valuation
$109.01M
Total Funding Raised
$17.97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LVIS Corporation is a neurotechnology company that develops AI-driven software tools to assist physicians in the diagnosis and treatment of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LVIS Corporation Comparables
Compare LVIS Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Persyst Development Corporation | 81% | |
| Neurogram | 80% | |
| BESA GmbH | 78% | |
LVIS Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 11, 2022 |
LVIS Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SK Inc. | Series A |
| Hico Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
NeuroMatch software received FDA 510(k) clearance.
- May 1, 2026
NeuroMatch software received certification from the Korean Ministry of Food and Drug Safety.
LVIS Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LVIS Corporation's valuation, stock price, and market status.